MIR4795

Across TCGA pan-cancer cohorts, MIR4795 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR4795’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where MIR4795 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR4795 is over-expressed in tumor, although a few such as THCA and COAD show the opposite, repressed pattern.

THCA, COAD, and STAD are the cancer types where MIR4795 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4795 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	II,III,IV	−0.496	<.001	7	view →
COAD	All	II,III,IV	−0.358	.002	5	view →
STAD	All	All	+0.229	.009	4	view →
KICH	Female	II,III,IV	−0.374	.016	3	view →
LUAD	Male	II,III,IV	+0.360	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR4795–THCA

Open the THCA breakdown →